Exact Mass: 588.2696416

Dinoflagellate luciferin

A member of the class of bilenes that is 1,2,3,21-tetrahydro-5,7-ethanobilene-a-19(16H),5(2)-dione which is substituted at positions 2, 8, 13 and 18 by methyl groups and at positions 1, 3, 12 and 17 by carboxy, 2-carboxyethyl, ethyl and vinyl groups, respectively (the 1S,2S,3S diastereoisomer).

8,12-Diethylbacteriochlorophyllide d

magnesium;3-[(21S,22S)-11,26-diethyl-16-(1-hydroxyethyl)-12,17,21-trimethyl-4-oxo-23,25-diaza-7,24-diazanidahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,5,8(26),9,11,13(25),14,16,18,20(23)-decaen-22-yl]propanoic acid

C34H36MgN4O4 (588.2586916)

Sandoricin

Methyl 2-[5,11-bis(acetyloxy)-13-(furan-3-yl)-16-hydroxy-6,6,8,12-tetramethyl-17-methylidene-15-oxo-2,14-dioxatetracyclo[7.7.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetic acid

Sandoricin is found in fruits. Sandoricin is a constituent of Sandoricum koetjape (santol). Constituent of Sandoricum koetjape (santol). Sandoricin is found in fruits.

Chlorophyll c

(2E)-3-[16-ethenyl-11-ethyl-4-hydroxy-3-(methoxycarbonyl)-12,17,21,26-tetramethyl-7,23,24,25-tetraazahexacyclo[18.2.1.1⁵,⁸.1¹⁰,¹³.1¹⁵,¹⁸.0²,⁶]hexacosa-1(23),2,4,6,8(26),9,11,13,15,17,19,21-dodecaen-22-yl]prop-2-enoic acid

C27H40N8O7 (588.3019810000001)

Chlorophyll c is widely distributed photosynthetic pigment in marine organisms, e.g. the diatom Nitzschia closteriu

Pentigetide

(2S)-2-[(Z)-{[(2S)-1-[(2S)-2-[(Z)-[(2S)-2-[(Z)-[(2S)-2-amino-3-carboxy-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-3-carboxypropanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino]-5-carbamimidamidopentanoic acid

C22H36N8O11 (588.2503426)

D007155 - Immunologic Factors > D007132 - Immunoglobulin Isotypes C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D007155 - Immunologic Factors > D007136 - Immunoglobulins D007155 - Immunologic Factors > D000906 - Antibodies Immunoglobulin E fragment. Immunoglobulin E fragment Pentigetide is a sythsis pepetide (Asp-Ser-Asp-Pro-Arg or D-S-D-P-R), also know as “HEPP” for “Human IgE Pentapeptide”. Pentigetide can not produce IgE inhibition in several different systems, due to the aspartic acids in HEPP changed into an asparagine[1].

(1RS,2RS)-2-(4-Hydroxyphenyl)-2-methyl-1-(9-(4,4,5,5,5-pentafluoropentyl)sulfinylnonyl)-1,2,3,4-tetrahydronaphth-6-ol

(1Rs,2Rs)-2-(4-Hydroxyphenyl)-2-methyl-1-(9-(4,4,5,5,5-pentafluoropentyl)sulphinylnonyl)-1,2,3,4-tetrahydronaphth-6-ol

C31H41F5O3S (588.2696416)

Cfp-aaf-pab

4-[(1-{[2-({2-[(1-carboxy-3-phenylpropyl)amino]-1-hydroxypropylidene}amino)-1-hydroxypropylidene]amino}-1-oxo-3-phenylpropan-2-yl)amino]benzoate

C32H36N4O7 (588.2583866)

Cilengitide

2-(5-benzyl-11-{3-[(diaminomethylidene)amino]propyl}-7-methyl-3,6,9,12,15-pentaoxo-8-(propan-2-yl)-1,4,7,10,13-pentaazacyclopentadecan-2-yl)acetic acid

N(2)-(4-Hydroxy-1-(1-methyl-1H-indol-3-yl)carbonyl-L-prolyl)-N-methyl-N-phenylmethyl-3-(2-naphthyl)-L-alaninamide

N-[1-[benzyl(methyl)amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]-4-hydroxy-1-(1-methylindole-3-carbonyl)pyrrolidine-2-carboxamide

C36H36N4O4 (588.2736416)

Flupentixol decanoate

2-(4-{3-[2-(trifluoromethyl)-9H-thioxanthen-9-ylidene]propyl}piperazin-1-yl)ethyl decanoic acid

rubriflorin H

trigoxyphin B

C34H36O9 (588.2359206)

A natural product found in Trigonostemon thyrsoideum.

OS-3

elaeodendroside T

C25H36N10O7 (588.2768306)

Glu Leu Gln Glu Gly

C24H40N6O11 (588.275493)

Pro Glu Glu Lys Ser

C24H40N6O11 (588.275493)

C32H44O10

NCGC00386085-01_C32H44O10_

C31H40O11_7,11-Methano-2H,4H-oxireno[1,8]cycloocta[1,2-f][2]benzopyran-8-acetic acid, 4-(3-furanyl)dodecahydro-alpha,11-dihydroxy-4a,7,9,9-tetramethyl-10-(2-methyl-1-oxopropoxy)-2,13-dioxo-, methyl ester, (alphaR,4R,4aR,7S,8S,10S,11S,11aR,12aS)

NCGC00347533-02_C31H40O11_7,11-Methano-2H,4H-oxireno[1,8]cycloocta[1,2-f][2]benzopyran-8-acetic acid, 4-(3-furanyl)dodecahydro-alpha,11-dihydroxy-4a,7,9,9-tetramethyl-10-(2-methyl-1-oxopropoxy)-2,13-dioxo-, methyl ester, (alphaR,4R,4aR,7S,8S,10S,11S,11aR,12aS)-

(1S,2R,4S,9R,10R,14S,15S,17S)-9-(furan-3-yl)-1-hydroxy-15-[(1R)-1-hydroxy-2-methoxy-2-oxoethyl]-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-17-yl 2-methylpropanoate

(1S,2R,4S,9R,10R,14S,15S,17S)-9-(furan-3-yl)-1-hydroxy-15-[(1R)-1-hydroxy-2-methoxy-2-oxoethyl]-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-17-yl 2-methylpropanoate

methyl 2-[5,11-bis(acetyloxy)-13-(furan-3-yl)-16-hydroxy-6,6,8,12-tetramethyl-17-methylidene-15-oxo-2,14-dioxatetracyclo[7.7.1.0^{1,12}.0^{3,8}]heptadecan-7-yl]acetate

Pentyde

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxypropanamido]-3-carboxypropanoyl]pyrrolidin-2-yl]formamido}-5-[(diaminomethylidene)amino]pentanoic acid

C22H36N8O11 (588.2503426)

D007155 - Immunologic Factors > D007132 - Immunoglobulin Isotypes C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D007155 - Immunologic Factors > D007136 - Immunoglobulins D007155 - Immunologic Factors > D000906 - Antibodies Pentigetide is a sythsis pepetide (Asp-Ser-Asp-Pro-Arg or D-S-D-P-R), also know as “HEPP” for “Human IgE Pentapeptide”. Pentigetide can not produce IgE inhibition in several different systems, due to the aspartic acids in HEPP changed into an asparagine[1].

(2aR,3R,6bS,7aR,8S,9S,11S,12S)-3-(furan-3-yl)-8-hydroxy-11-((R)-1-hydroxy-2-methoxy-2-oxoethyl)-2a,10,10,12-tetramethyl-5,13-dioxododecahydro-2H,3H-8,12-methanooxireno[2,3:1,8]cycloocta[1,2-f]isochromen-9-yl isobutyrate

(2aR,3R,6bS,7aR,8S,9S,11S,12S)-3-(furan-3-yl)-8-hydroxy-11-((R)-1-hydroxy-2-methoxy-2-oxoethyl)-2a,10,10,12-tetramethyl-5,13-dioxododecahydro-2H,3H-8,12-methanooxireno[2,3:1,8]cycloocta[1,2-f]isochromen-9-yl isobutyrate

C33H43F3N2O2S (588.2997174000001)

Flupentixol decanoate

D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

Cyclo(-Arg-Ala-Asp-D-Phe-Val)

C27H40N8O7 (588.3019810000001)

Z-Gly-Pro-Gly-Gly-Pro-Ala-OH

C27H36N6O9 (588.2543646)

Cilengitide

C27H40N8O7 (588.3019810000001)

C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C2144 - Endothelial-Specific Integrin/Survival Signaling Inhibitor D009676 - Noxae > D011042 - Poisons > D014688 - Venoms

(S)-2-[(S)-2-((S)-1-Ethoxycarbonyl-3-phenylpropylamino)propionyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid benzyl ester

C34H40N2O7 (588.283537)

Procaine penicillin

Penicillin G Procaine

C29H40N4O7S (588.261757)

D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

BAPTA tetraethyl ester

C30H40N2O10 (588.268282)

mesobilirubin

C33H41ClN6O2 (588.2979356000001)

N,N-Bis(naphthalene-2-yl)-N,N-bis(phenyl)benzidine

C44H32N2 (588.2565352)

N,N′-di(1-naphthyl)-N,N′-diphenylbenzidine

C44H32N2 (588.2565352)

1,3-Diphenylguanidinium phthalate

C34H32N6O4 (588.2484912)

1,1-(1,3-Propanediyl)bis[1,1-bis(2-methoxy-5-methylphenyl)phosphine]

C35H42O4P2 (588.2558192)

Eusynthomycin

Chloramphenicol stearate

C29H46Cl2N2O6 (588.2732756)

THIQ

Flupentixol decanoate, (Z)-

C33H43F3N2O2S (588.2997174000001)

(2S,4R)-N-[(2S)-1-[benzyl(methyl)amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]-4-hydroxy-1-(1-methylindole-3-carbonyl)pyrrolidine-2-carboxamide

C36H36N4O4 (588.2736416)

2-[(8S,11S)-11-{(1R)-1-Hydroxy-2-[isopentyl(phenylsulfonyl)amino]ethyl}-6,9-dioxo-2-oxa-7,10-diazabicyclo[11.2.2]heptadeca-1(15),13,16-trien-8-YL]acetamide

C29H40N4O7S (588.261757)

Ziritaxestat

C30H33FN8O2S (588.243109)

C78273 - Agent Affecting Respiratory System

Chlorophyll c

Reduced dinoflagellate luciferin

C33H40N4O6-2 (588.29477)

a Phycourobilin

C33H40N4O6-2 (588.29477)

3-[2-[[3-(2-carboxylatoethyl)-5-[(3-ethyl-4-methyl-5-oxo-1,2-dihydropyrrol-2-yl)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-1,2-dihydropyrrol-2-yl)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate

3-[2-[[3-(2-carboxylatoethyl)-5-[(3-ethyl-4-methyl-5-oxo-1,2-dihydropyrrol-2-yl)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-1,2-dihydropyrrol-2-yl)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate

C33H40N4O6-2 (588.29477)

3-[11,16-Bis(ethenyl)-4-hydroxy-3-methoxycarbonyl-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,3,5,8(26),9,11,13(25),14,16,18,20(23),21-dodecaen-22-yl]propanoic acid

beta-D-Manp-(1->4)-beta-D-GlcpNAc-(1->4)-D-GlcNAc-OH

D-Galp-(1->4)-D-GlcpNAc-(1->3)-D-GalNAc-OH

N-[(3R,4R,5S,6R)-2-[(2S,3R,4S,5R)-2-Acetamido-1,4,5,6-tetrahydroxyhexan-3-yl]oxy-4-hydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]acetamide

(E)-3-(16-ethenyl-11-ethyl-4-hydroxy-3-methoxycarbonyl-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18,20(23),21-dodecaen-22-yl)prop-2-enoic acid

(E)-3-(16-ethenyl-11-ethyl-4-hydroxy-3-methoxycarbonyl-12,17,21,26-tetramethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18,20(23),21-dodecaen-22-yl)prop-2-enoic acid

[(1S,2R,4S,5R,9R,10R,14S,15S,17S)-9-(furan-3-yl)-1-hydroxy-15-[(1R)-1-hydroxy-2-methoxy-2-oxoethyl]-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.02,4.04,13.05,10]octadecan-17-yl] 2-methylpropanoate

[(1S,2R,4S,5R,9R,10R,14S,15S,17S)-9-(furan-3-yl)-1-hydroxy-15-[(1R)-1-hydroxy-2-methoxy-2-oxoethyl]-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.02,4.04,13.05,10]octadecan-17-yl] 2-methylpropanoate

C29H48O10S (588.2968028)

Bemfivastatin

C34H37FN2O6 (588.2635514)

Bemfivastatin (PPD 10558) is an orally active, HMG-CoA Reductase (HMGCR) inhibitor, also known as Statin. Bemfivastatin enhances the activity of liver extraction. Bemfivastatin exhibits little developmental toxicity effects in pregnant rats and rabbits via daily oral doses during organogenesis period. The no observed adverse effect level (NOAEL) are ≥320?mg/kg/day for rats developmental toxicity, 12.5?mg/kg/day for rabbits maternal toxicity, and 25?mg/kg/day for rabbits developmental toxicity, respectively. Bemfivastatin can be used for research on Statin-related hypercholesterolemic myalgia with inability to tolerate statins[1][2].

(1r,2s,3s,5s,8r,9s,10r,11s,13r,16s)-11,16-bis(acetyloxy)-5,8,9-trihydroxy-3-(2-hydroxypropan-2-yl)-6,10-dimethyl-14-oxatetracyclo[8.6.0.0³,⁷.0¹³,¹⁶]hexadec-6-en-2-yl benzoate

methyl 2-[(1s,3r,4s,5s,7s,8s,9r,12s,13s,16s)-4,16-bis(acetyloxy)-13-(furan-3-yl)-5-hydroxy-6,6,8,12-tetramethyl-17-methylidene-15-oxo-2,14-dioxatetracyclo[7.7.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetate

methyl 2-[(1s,3r,4s,5s,7s,8s,9r,12s,13s,16s)-4,16-bis(acetyloxy)-13-(furan-3-yl)-5-hydroxy-6,6,8,12-tetramethyl-17-methylidene-15-oxo-2,14-dioxatetracyclo[7.7.1.0¹,¹².0³,⁸]heptadecan-7-yl]acetate

(1s,2r,4s,5r,9r,10r,13r,14s,15s,17s)-9-(furan-3-yl)-1-hydroxy-15-[(1r)-1-hydroxy-2-methoxy-2-oxoethyl]-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-17-yl 2-methylpropanoate

(1s,2r,4s,5r,9r,10r,13r,14s,15s,17s)-9-(furan-3-yl)-1-hydroxy-15-[(1r)-1-hydroxy-2-methoxy-2-oxoethyl]-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-17-yl 2-methylpropanoate

(1r,2s,3r,10s,19r,22s,23s,24r,26r,29r)-10-acetyl-1,22-dihydroxy-2,22-dimethyl-5,16-dioxo-4,11,17,25-tetraoxahexacyclo[21.3.1.1³,²⁶.1¹⁰,¹⁴.0²,¹⁹.0¹⁹,²⁴]nonacosa-6,14-dien-29-yl acetate

(1r,2s,3r,10s,19r,22s,23s,24r,26r,29r)-10-acetyl-1,22-dihydroxy-2,22-dimethyl-5,16-dioxo-4,11,17,25-tetraoxahexacyclo[21.3.1.1³,²⁶.1¹⁰,¹⁴.0²,¹⁹.0¹⁹,²⁴]nonacosa-6,14-dien-29-yl acetate

7-[(acetyloxy)methyl]-4-({[3,4-bis(acetyloxy)-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-7-hydroxy-1h,4ah,5h,6h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate

(1r,2s,3r,5s,8r,9r,10s,11s,13r,16s)-2,16-bis(acetyloxy)-5,8,11-trihydroxy-3-(2-hydroxypropan-2-yl)-6,10-dimethyl-14-oxatetracyclo[8.6.0.0³,⁷.0¹³,¹⁶]hexadec-6-en-9-yl benzoate

6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-14-(non-1-en-1-yl)-5-oxo-16-(prop-1-en-2-yl)-9,13,15,19-tetraoxahexacyclo[12.4.1.0¹,¹¹.0²,⁶.0⁸,¹⁰.0¹²,¹⁶]nonadec-3-en-17-yl acetate

(2s,2's,4'ar,4'bs,7's,8'ar,10'ar)-4,5-bis(acetyloxy)-6-chloro-2',4'b,7,8',8',10'a-hexamethyl-2',3',4',4'a,5',6',7',8'a,9',10'-decahydro-3h-spiro[1-benzofuran-2,1'-phenanthren]-7'-yl acetate

C33H45ClO7 (588.285365)

7,7'-dimethoxy-3,3'-dimethyl-8,8'-bis(3-methylbut-2-en-1-yl)-9h,9'h-[2,2'-bicarbazole]-1,1'-diol

C38H40N2O4 (588.298792)

11,16-bis(acetyloxy)-5,8,9-trihydroxy-3-(2-hydroxypropan-2-yl)-6,10-dimethyl-14-oxatetracyclo[8.6.0.0³,⁷.0¹³,¹⁶]hexadec-6-en-2-yl benzoate

(3r,6s,12r,15s,18s)-3,12-dibenzyl-5,14-dihydroxy-15-isopropyl-16-oxa-1,4,10,13-tetraazatricyclo[16.3.0.0⁶,¹⁰]henicosa-4,13-diene-2,11,17-trione

(1r,2s,3s,5s,8r,9r,10s,11s,13r,16s)-2,16-bis(acetyloxy)-5,9,11-trihydroxy-3-(2-hydroxypropan-2-yl)-6,10-dimethyl-14-oxatetracyclo[8.6.0.0³,⁷.0¹³,¹⁶]hexadec-6-en-8-yl benzoate

(1s,3r,5s,6s,7s,9r,10r,13r,14r,16s,18r,20r,22s,24s,26r)-7,13,26-trihydroxy-1-methoxy-5,9,24-trimethyl-10-(6-oxopyran-3-yl)-2,15,21,23-tetraoxaheptacyclo[20.3.1.0³,²⁰.0⁵,¹⁸.0⁶,¹⁴.0⁹,¹³.0¹⁴,¹⁶]hexacosan-8-one

(1s,3r,5s,6s,7s,9r,10r,13r,14r,16s,18r,20r,22s,24s,26r)-7,13,26-trihydroxy-1-methoxy-5,9,24-trimethyl-10-(6-oxopyran-3-yl)-2,15,21,23-tetraoxaheptacyclo[20.3.1.0³,²⁰.0⁵,¹⁸.0⁶,¹⁴.0⁹,¹³.0¹⁴,¹⁶]hexacosan-8-one

(3s,6s,12s,15s,18r)-3,12-dibenzyl-5,14-dihydroxy-15-isopropyl-16-oxa-1,4,10,13-tetraazatricyclo[16.3.0.0⁶,¹⁰]henicosa-4,13-diene-2,11,17-trione

3-(2-{[(2z)-3-(2-carboxyethyl)-5-{[(2z,3r,4r)-3-ethyl-5-hydroxy-4-methyl-3,4-dihydropyrrol-2-ylidene]methyl}-4-methylpyrrol-2-ylidene]methyl}-5-{[(2r)-4-ethenyl-5-hydroxy-3-methyl-2h-pyrrol-2-yl]methyl}-4-methyl-1h-pyrrol-3-yl)propanoic acid

3-(2-{[(2z)-3-(2-carboxyethyl)-5-{[(2z,3r,4r)-3-ethyl-5-hydroxy-4-methyl-3,4-dihydropyrrol-2-ylidene]methyl}-4-methylpyrrol-2-ylidene]methyl}-5-{[(2r)-4-ethenyl-5-hydroxy-3-methyl-2h-pyrrol-2-yl]methyl}-4-methyl-1h-pyrrol-3-yl)propanoic acid

(1r,2s,3s,5s,8r,9r,10r,11s,13r,16s)-11,16-bis(acetyloxy)-5,8,9-trihydroxy-3-(2-hydroxypropan-2-yl)-6,10-dimethyl-14-oxatetracyclo[8.6.0.0³,⁷.0¹³,¹⁶]hexadec-6-en-2-yl benzoate

(3r,5s,7r,9s,10s,12r,14s,15s,18r,19r,20r,22s,23r)-14-formyl-9,10,22-trihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1(25)-en-20-yl acetate

(3r,5s,7r,9s,10s,12r,14s,15s,18r,19r,20r,22s,23r)-14-formyl-9,10,22-trihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1(25)-en-20-yl acetate

(1s,2s,5s,6s,7s,9r,12r)-12-(acetyloxy)-2-hydroxy-2,6,10,10-tetramethyl-5-{[(2e)-3-phenylprop-2-enoyl]oxy}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-7-yl (2e)-3-phenylprop-2-enoate

(1s,2s,4s,4as,5r,8as)-1-[(2s)-2-(furan-3-yl)-2-hydroxyethyl]-2,5-dihydroxy-5-(methoxycarbonyl)-1,4a-dimethyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydronaphthalene-2-carboxylic acid

(1s,2s,4s,4as,5r,8as)-1-[(2s)-2-(furan-3-yl)-2-hydroxyethyl]-2,5-dihydroxy-5-(methoxycarbonyl)-1,4a-dimethyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydronaphthalene-2-carboxylic acid

(1r,2r,6s,7s,8r,10s,11r,12r,14s,16s,17r,18r)-6,7-dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-14-[(1e)-non-1-en-1-yl]-5-oxo-16-(prop-1-en-2-yl)-9,13,15,19-tetraoxahexacyclo[12.4.1.0¹,¹¹.0²,⁶.0⁸,¹⁰.0¹²,¹⁶]nonadec-3-en-17-yl acetate

12,14-bis(acetyloxy)-6-(2-hydroxy-5-oxo-2h-furan-3-yl)-1,7,11,15,15-pentamethyl-3-oxapentacyclo[8.8.0.0²,⁴.0²,⁷.0¹¹,¹⁶]octadecan-18-yl acetate

(1'r,2'r,3s,3ar,4s,5's,9's,9as,9br,10's,11's)-2'-hydroxy-2',6,9,11'-tetramethyl-6'-methylidene-2,7,7'-trioxo-4,5,9a,9b-tetrahydro-3ah-8'-oxaspiro[azuleno[4,5-b]furan-3,12'-tetracyclo[9.2.2.0¹,¹⁰.0⁵,⁹]pentadecan]-14'-en-4-yl (2e)-2-methylbut-2-enoate

(1'r,2'r,3s,3ar,4s,5's,9's,9as,9br,10's,11's)-2'-hydroxy-2',6,9,11'-tetramethyl-6'-methylidene-2,7,7'-trioxo-4,5,9a,9b-tetrahydro-3ah-8'-oxaspiro[azuleno[4,5-b]furan-3,12'-tetracyclo[9.2.2.0¹,¹⁰.0⁵,⁹]pentadecan]-14'-en-4-yl (2e)-2-methylbut-2-enoate

(2s,5s,6r)-2-[(2r,4ar,6r,8as)-6-[(2s,5r)-5-bromo-2,6,6-trimethyloxan-2-yl]-8a-methyl-hexahydro-2h-pyrano[3,2-b]pyran-2-yl]-6,10-dimethylundec-9-ene-2,5,6-triol

C30H53BrO6 (588.3025298)

(1'r,2'r,3s,3ar,4s,5's,9's,9as,9br,10's,11's)-2'-hydroxy-2',6,9,11'-tetramethyl-6'-methylidene-2,7,7'-trioxo-4,5,9a,9b-tetrahydro-3ah-8'-oxaspiro[azuleno[4,5-b]furan-3,12'-tetracyclo[9.2.2.0¹,¹⁰.0⁵,⁹]pentadecan]-14'-en-4-yl 3-methylbut-2-enoate

3,12-dibenzyl-5,14-dihydroxy-15-isopropyl-16-oxa-1,4,10,13-tetraazatricyclo[16.3.0.0⁶,¹⁰]henicosa-4,13-diene-2,11,17-trione

(1s,2r,4s,5r,9r,10s,13r,14s,15s,17r)-9-(furan-3-yl)-1-hydroxy-15-[(1r)-1-hydroxy-2-methoxy-2-oxoethyl]-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-17-yl 2-methylpropanoate

(1s,2r,4s,5r,9r,10s,13r,14s,15s,17r)-9-(furan-3-yl)-1-hydroxy-15-[(1r)-1-hydroxy-2-methoxy-2-oxoethyl]-10,14,16,16-tetramethyl-7,18-dioxo-3,8-dioxapentacyclo[12.3.1.0²,⁴.0⁴,¹³.0⁵,¹⁰]octadecan-17-yl 2-methylpropanoate

(1s,2s,4r,4as,5r,8as)-1-[(2s)-2-(furan-3-yl)-2-hydroxyethyl]-2,5-dihydroxy-5-(methoxycarbonyl)-1,4a-dimethyl-4-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydronaphthalene-2-carboxylic acid

(1s,2s,4r,4as,5r,8as)-1-[(2s)-2-(furan-3-yl)-2-hydroxyethyl]-2,5-dihydroxy-5-(methoxycarbonyl)-1,4a-dimethyl-4-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydronaphthalene-2-carboxylic acid

(3r,5s,7r,9s,10s,12r,14s,15s,18r,19r,20r,22s,23r)-14-formyl-10,20,22-trihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1(25)-en-9-yl acetate

(3r,5s,7r,9s,10s,12r,14s,15s,18r,19r,20r,22s,23r)-14-formyl-10,20,22-trihydroxy-7,18-dimethyl-19-(5-oxo-2h-furan-3-yl)-4,6,11-trioxahexacyclo[12.11.0.0³,¹².0⁵,¹⁰.0¹⁵,²³.0¹⁸,²²]pentacos-1(25)-en-9-yl acetate

(1r,2s,3s,5s,8r,9r,10r,11s,13r,16s)-2,16-bis(acetyloxy)-5,8,9-trihydroxy-3-(2-hydroxypropan-2-yl)-6,10-dimethyl-14-oxatetracyclo[8.6.0.0³,⁷.0¹³,¹⁶]hexadec-6-en-11-yl benzoate

7,13,26-trihydroxy-1-methoxy-5,9,24-trimethyl-10-(6-oxopyran-3-yl)-2,15,21,23-tetraoxaheptacyclo[20.3.1.0³,²⁰.0⁵,¹⁸.0⁶,¹⁴.0⁹,¹³.0¹⁴,¹⁶]hexacosan-8-one

(1r,2s,3as,3br,7s,9ar,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-7-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl acetate

(1r,2s,3as,3br,7s,9ar,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-7-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl acetate

(1s,2r,4s,4as,5r,8as)-1-[(2s)-2-(furan-3-yl)-2-hydroxyethyl]-2,5-dihydroxy-5-(methoxycarbonyl)-1,4a-dimethyl-4-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydronaphthalene-2-carboxylic acid

(1s,2r,4s,4as,5r,8as)-1-[(2s)-2-(furan-3-yl)-2-hydroxyethyl]-2,5-dihydroxy-5-(methoxycarbonyl)-1,4a-dimethyl-4-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-hexahydronaphthalene-2-carboxylic acid

(2e)-3-[16-ethenyl-11-ethyl-4-hydroxy-3-(methoxycarbonyl)-12,17,21,26-tetramethyl-7,23,24,25-tetraazahexacyclo[18.2.1.1⁵,⁸.1¹⁰,¹³.1¹⁵,¹⁸.0²,⁶]hexacosa-1(23),2(6),3,5(26),8,10(25),11,13,15,17,19,21-dodecaen-22-yl]prop-2-enoic acid

(2e)-3-[16-ethenyl-11-ethyl-4-hydroxy-3-(methoxycarbonyl)-12,17,21,26-tetramethyl-7,23,24,25-tetraazahexacyclo[18.2.1.1⁵,⁸.1¹⁰,¹³.1¹⁵,¹⁸.0²,⁶]hexacosa-1(23),2(6),3,5(26),8,10(25),11,13,15,17,19,21-dodecaen-22-yl]prop-2-enoic acid

(1r,3r,6r,7r,9r,10r,11s,12s,15r,17r,18s)-9-(acetyloxy)-7,12,15-trihydroxy-17-(2-hydroxypropan-2-yl)-3,10,14-trimethyl-2,4,19-trioxapentacyclo[8.7.1.1³,⁶.0⁶,¹⁸.0¹³,¹⁷]nonadec-13-en-11-yl benzoate

(1r,3r,6r,7r,9r,10r,11s,12s,15r,17r,18s)-9-(acetyloxy)-7,12,15-trihydroxy-17-(2-hydroxypropan-2-yl)-3,10,14-trimethyl-2,4,19-trioxapentacyclo[8.7.1.1³,⁶.0⁶,¹⁸.0¹³,¹⁷]nonadec-13-en-11-yl benzoate

14-(acetyloxy)-3,5,22-trihydroxy-11,15,17,22-tetramethyl-4,21-dioxo-8,20-dioxaheptacyclo[13.10.0.0²,¹².0⁵,¹¹.0⁷,⁹.0¹⁶,²⁴.0¹⁹,²³]pentacos-18-en-10-yl acetate

6-(acetyloxy)-4-({[3-(acetyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-7-[(acetyloxy)methyl]-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate

(3as,6s)-3a-(6-{[(1s,12s,14s)-14-hydroxy-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17)-trien-4-yl]methyl}-2h-1,3-benzodioxol-5-yl)-6-methoxy-1-methyl-2,6,7,7a-tetrahydroindol-3-one

(3as,6s)-3a-(6-{[(1s,12s,14s)-14-hydroxy-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17)-trien-4-yl]methyl}-2h-1,3-benzodioxol-5-yl)-6-methoxy-1-methyl-2,6,7,7a-tetrahydroindol-3-one

C34H40N2O7 (588.283537)

(2s,3as,4s,4ar,5r,6s,8s,8as,9r,10r)-4,8-bis(acetyloxy)-2,6,10-trihydroxy-3a-(2-hydroxypropan-2-yl)-1,8a-dimethyl-3,4,4a,6,7,8,9,10-octahydro-2h-spiro[cyclohexa[f]azulene-5,2'-oxiran]-9-yl benzoate

(1s,4as,6s,7s,7as)-6-(acetyloxy)-4-({[(2r,3r,4s,5s,6r)-3-(acetyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-7-[(acetyloxy)methyl]-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate

(1s,4as,6s,7s,7as)-6-(acetyloxy)-4-({[(2r,3r,4s,5s,6r)-3-(acetyloxy)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-7-[(acetyloxy)methyl]-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-1-yl 3-methylbutanoate

6-[(1r,3ar,5ar,6r,7s,9as,11s,11ar)-11-(acetyloxy)-7-hydroxy-6-(hydroxymethyl)-3a,6,9a,11a-tetramethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

6-[(1r,3ar,5ar,6r,7s,9as,11s,11ar)-11-(acetyloxy)-7-hydroxy-6-(hydroxymethyl)-3a,6,9a,11a-tetramethyl-3,4,10-trioxo-1h,2h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-4-oxoheptanoic acid

(1s,2s)-2-[(1r,2s,3s,7r,10s,13r,15s,16s,17r,18r)-2,15-dihydroxy-9,9,18-trimethyl-5,14-dioxo-4,8,21-trioxahexacyclo[13.5.1.0¹,¹³.0³,⁷.0³,¹⁰.0¹⁶,¹⁸]henicosan-17-yl]-1-[(2s)-4-methyl-5-oxo-2h-furan-2-yl]propyl acetate

3-[(2z,5e)-2-{[3-(2-carboxyethyl)-5-{[(2z,3r,4r)-3-ethyl-5-hydroxy-4-methyl-3,4-dihydropyrrol-2-ylidene]methyl}-4-methyl-1h-pyrrol-2-yl]methylidene}-5-[(4-ethyl-3-methyl-5-oxopyrrol-2-yl)methylidene]-4-methyl-1h-pyrrol-3-yl]propanoic acid

3-[(2z,5e)-2-{[3-(2-carboxyethyl)-5-{[(2z,3r,4r)-3-ethyl-5-hydroxy-4-methyl-3,4-dihydropyrrol-2-ylidene]methyl}-4-methyl-1h-pyrrol-2-yl]methylidene}-5-[(4-ethyl-3-methyl-5-oxopyrrol-2-yl)methylidene]-4-methyl-1h-pyrrol-3-yl]propanoic acid

(1r,2r,3as,3br,7s,9as,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-7-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl acetate

(1r,2r,3as,3br,7s,9as,9bs,11ar)-3a-hydroxy-9a,11a-dimethyl-1-(6-oxopyran-3-yl)-7-{[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-1h,2h,3h,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-2-yl acetate

2,16-bis(acetyloxy)-5,8,9-trihydroxy-3-(2-hydroxypropan-2-yl)-6,10-dimethyl-14-oxatetracyclo[8.6.0.0³,⁷.0¹³,¹⁶]hexadec-6-en-11-yl benzoate